ZVRA holder plans Rule 144 sale of 4,080 shares

A holder of ZVRA common stock filed a Rule 144 notice to sell 4,080 shares, with an aggregate market value of $36,148.80.

Accepted by SEC EDGAR 01/30/2026 - 04:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of ZVRA common stock filed a Rule 144 notice to sell 4,080 shares, with an aggregate market value of $36,148.80. The planned sale is through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/30/2026.

The shares come from restricted stock units acquired from the issuer on 01/30/2026 in the same amount of 4,080 units. The form notes that there are 56,297,535 ZVRA common shares outstanding at the time of this notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ZVRA Form 144 filing disclose?

The Form 144 shows a ZVRA shareholder intends to sell 4,080 common shares under Rule 144. These shares have an aggregate market value of $36,148.80 and will be sold on NASDAQ through Morgan Stanley Smith Barney LLC, subject to market conditions and Rule 144 requirements.

How many ZVRA shares are involved in this Rule 144 sale?

The notice covers 4,080 ZVRA common shares. The filing lists an aggregate market value of $36,148.80 for these shares. It also states that 56,297,535 ZVRA common shares are outstanding, providing context for the size of the planned sale.

What is the source of the ZVRA shares being sold under Form 144?

The shares come from restricted stock units in ZVRA common stock. The Form 144 states that 4,080 units were acquired from the issuer as restricted stock units on 01/30/2026, matching the number of shares now listed for potential sale under Rule 144.

Which broker and exchange are used in the ZVRA Form 144 sale?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned ZVRA trade. The shares are to be sold on the NASDAQ exchange, aligning with the listing venue shown in the Form 144 securities information table.

When is the ZVRA Rule 144 sale expected to occur?

The Form 144 lists an approximate sale date of 01/30/2026 for the 4,080 ZVRA shares. This date reflects when the holder expects to begin selling the shares on NASDAQ through Morgan Stanley Smith Barney LLC, subject to Rule 144 conditions.

How does the planned ZVRA sale compare with total shares outstanding?

The Form 144 indicates there are 56,297,535 ZVRA common shares outstanding. The planned sale of 4,080 shares is presented against this outstanding figure in the table, giving investors a sense of the relative size of the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001788524
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZEVRA THERAPEUTICS INC
SEC File Number	001-36913
Address of Issuer	1180 Celebration Boulevard, Suite 103 Celebration FLORIDA 34747
Phone	3219393416
Name of Person for Whose Account the Securities are To Be Sold	RAHSAAN THOMPSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Secretary

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4080	36148.80	56297535	01/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Restricted Stock Units	Issuer			4080	01/30/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rahsaan Thompson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)